The three places have successively issued this notice, and the market of Chinese medicine decoction pieces may be deeply affected

 Decoction pieces of traditional Chinese medicine are one of the three pillars of China's traditional Chinese medicine industry.
It is a traditional Chinese medicine that can be directly used in traditional Chinese medicine after being processed according to the theory of traditional Chinese medicine and the processing method of traditional Chinese medicine
.
However, as the "hardest hit area" of unqualified medicines, Chinese herbal decoction pieces have always had a low degree of industry concentration
.
The industry said that the development of centralized procurement will help standardize the quality of Chinese herbal medicine pieces, and the industry concentration will also be improved
.
It is understood that recently, Shanxi, Shandong, Ningxia and other provinces have successively issued the "Notice on Carrying out the Data Reporting Work of Some TCM Decoction Pieces", and organized medical institutions to fill in the information such as purchasing demand.
Traditional Chinese medicine decoction pieces entered the era of centralized procurement
.
For example, on March 10, the Shanxi Provincial Centralized Bidding and Purchasing Center for Pharmaceutical Equipment stated that in accordance with the requirements of the Sanming Procurement Alliance (National) Office's "Notice on Carrying out the Data Reporting Work for Some Varieties of Chinese Herbal Pieces", medical institutions in Shanxi Province were organized to carry out centralized collection of Chinese medicine pieces.
Procurement-related product procurement data filling and reporting work
.
According to the industry, reporting volume is a key step in centralized procurement
.
This means that after chemicals, insulin, high-value consumables, etc.
have entered the centralized procurement of medicines, Chinese herbal decoction pieces have also officially entered the centralized procurement
.
It is reported that the collected reports in Shanxi Province include Astragalus, Codonopsis, Honeysuckle, Angelica, Safflower, Gastrodia, Ophiopogon, Rhizoma Coptidis, Taizishen, Baishao, Licorice, Dilong, Salvia, Scutellaria, Chinese yam, 21 varieties of Chinese herbal medicines, including dandelion, peony bark, and platycodon grandiflorum, are all common varieties
.
Recently, Shandong Internet Chinese Medicinal Materials Trading Center also issued the "Notice on Carrying Out the Data Reporting Work for Some TCM Decoction Pieces"
.
Although the notice does not specify which pieces of traditional Chinese medicine need to be filled in with relevant data, there are media reports that a report volume circulating in the industry shows that there may be more than 190 kinds of pieces of traditional Chinese medicine that need to be collected, including Salvia, Radix Salviae miltiorrhiza, Bupleurum, licorice and angelica and other common Chinese herbal pieces
.
In addition, on March 8, the Ningxia Hui Autonomous Region Public Resource Trading Network also issued the "Notice of the Autonomous Region Medical Insurance Bureau on Carrying out Data Reporting Work for Some TCM Decoction Pieces", officially confirming that the National Inter-Provincial Traditional Chinese Medicine (Material) Procurement Alliance has begun to start TCM decoction pieces.
volume of news
.
The quality of Chinese herbal decoction pieces has always been uneven, and centralized procurement can help standardize the quality of Chinese herbal decoction pieces, which is expected to force enterprises to improve product quality
.
For example, the list of Chinese herbal decoction pieces jointly purchased by Shanxi Province this time sets two specifications for each variety: selection and standardization, and specification registration requirements for each specification.
For example, astragalus selection requires thick slices, diameter ≥ 0.
8cm; For Astragalus, thick slices are required, with a diameter of ≥0.
5cm
.
Industry insiders said that previously, the standardized management of Chinese herbal medicines faced challenges such as lack of planting bases for Chinese herbal medicines, easy price hikes, and complicated circulation links
.
The centralized procurement makes clear requirements for varieties and specifications, or forces the market of traditional Chinese medicine pieces to standardize and standardize
.
The data shows that in recent years, the market of Chinese herbal decoction pieces has continued to grow, and its proportion in the pharmaceutical industry has shown an increasing trend year by year
.
For example, from 2011 to 2018, the average annual compound growth rate of China's traditional Chinese medicine decoction pieces processing market was 17.
1%, from 87.
4 billion yuan to 263.
7 billion yuan
.
At present, there are more than 1,000 Chinese herbal decoction pieces processing enterprises in China, but it is worth mentioning that most of the production enterprises are small in scale, with many production varieties, and the industry market concentration is low
.
According to the industry, with the development of centralized procurement, the market of Chinese herbal medicines may achieve survival of the fittest, and the industrial concentration can be improved, forming a group of enterprises with strength and service capabilities, so as to better promote the further development of the Chinese herbal medicines market
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.